Vote of Confidence, page-18

Hey Kappa,

Like you, I don't enjoy what Harvett is pointing out, but it happens to be the facts. And worse still, Noxopharm has gone completely silent, and is telling its shareholders nothing. I know that they're a small lean company and i don't expect to be spoon-fed. But when a critical early milestone is being missed, I don't expect radio silence.

This is the first time I feel in danger of being disappointed by Dr Kelly after many years of investing in his companies. I hope this lack of communication is just a temporary aberration which he will soon explain to our satisfaction.